Crispr Therapeutics AG
CRSP
$49.990.00%
At close · Nov 3, 2026
Mkt cap
$5.42B
EV/Sales
1445.3
P/E ratio
—
FY2025 Revenue
$3.51M
EPS (TTM)
−$4.71
Gross Margin (FY2025)
—
Profit Margin (FY2025)
−16569.77%
Beta
1.73
Div yield
—
Sector
Healthcare
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Latest
CRSP earnings
Analysts
RatingsSector-relative grades for valuation, growth, profitability, momentum and revisions
Form 4 trades, last 90 days
Latest SEC filings
Source: SEC EDGAR · Latest filing Nov 2, 2026
Latest stored headlines
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported CRSP revenue for 2025-12-31 was $3.5M. Net income was -$581.6M. Revenue was down 90.6% from 2024-12-31 to 2025-12-31. CRSP currently screens at market cap $5.42B.
Use this CRSP research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full CRSP income, balance, and cash tables.
Crispr Therapeutics AG (CRSP) is a biotechnology company in the Healthcare sector.
Latest cached Crispr Therapeutics AG (CRSP) revenue for Dec 31, 2025 was $3.5M. Net income was -$581.6M. Statements: https://lician.com/financials/crsp
Crispr Therapeutics AG (CRSP) market capitalization is $5.42B on the latest cached snapshot.
Crispr Therapeutics AG (CRSP) cached previous close $49.99; day range $49.62 – $51.86; volume 1,286,124. Session quote: https://lician.com/quote/crsp
Crispr Therapeutics AG (CRSP) latest cached earnings event is "CRSP earnings" on Aug 3, 2026. Earnings calendar: https://lician.com/earnings
The latest cached CRSP filing is 8-K · Nov 2, 2026. Filings: https://lician.com/sec/crsp
SEC filings · latest fiscal year FY2025
Free shows the newest 2 years. FY2022–FY2023 on Pro
−90.6%
Revenue growth year over year
10-Q results and the earnings calendar
Revenue and EPS are GAAP diluted from the 10-Q. Beat or miss compares the calendar's actual with its estimate on the same basis (adj.), or revenue with the revenue estimate.
Institutional holders from SEC 13F filings
Quant rating
MetricsHow it works1.61Sell
Lician Quant Grades · vs 548 Healthcare stocks · Nov 4, 2026
Next earnings
Thu, Feb 11Lician estimate
Time not announced · in 99 days
EPS est. —
Lician projectionEarnings
Short interest
17.3%of float
10.2 days to cover
−12.0% vs prior report
FINRA · settled Oct 15Short data
52-week range
$44.34$61.89
Price $49.99 · 19.2% below high
Low $44.34, high $61.89, last $49.99.Daily closesChart
Get alerted when CRSP confirms or moves its Feb 11 report
Free account, no card. Earnings date alerts are free for every stock on your watchlist; beat/miss results come with Pro.